Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Genet Med. 2023 May 6;25(9):100880. doi: 10.1016/j.gim.2023.100880

Figure 1.

Figure 1.

A. Molecular diagnostic yield (proportion of positive/likely positive clinical interpretations) of targeted gene panel (TGP) testing and genome sequencing (GS) across the largest population groups by self-report. Diagnostic yield was higher for GS compared to TGP testing in self-reported Hispanic/Latino(a) and White/European American but not in Black/African American population groups. B. Rates of positive/likely positive and uncertain clinical interpretations across population groups. Rates of positive/likely positive clinical interpretations (i.e., diagnostic yield) did not vary significantly across groups. Rates of uncertain clinical interpretations were higher in self-reported Black/African American than White/European American population groups. Error bars represent 95% confidence intervals. NS, not significant.